Login
Navigate Fool.com
Will NVS beat
the market?

Novartis

NYSE: NVS

Community Rating: 4 Stars: Favorite

74.15 -0.86 (-1.15%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.53
Previous Close $75.01
Daily Range $73.50 - $74.16
52-Week Range $51.20 - $75.67
Market Cap $182.2B
P/E Ratio 19.28
Dividend (Yield) $2.53 (2.7%)
Ex-Dividend Date
Dividend Pay Date
02/26/13
04/05/13
Volume 1,092,063
Average Daily Volume 1,481,047
Current FY EPS $5.11

How do you think NVS
will perform against the market?

Top NVS Bull/Bear Pitches

 

MarginofSafetyIn (< 20)
Submitted November 21, 2010

Novartis Review: Could be a good pharma pick Intro Novartis is a “large Pharma” company with 5 major operating units: Branded pharmaceuticals, Generic pharmaceuticals, diagnostics, vaccines and follo … More

0 Replies Reply Report this Post
 

nipous (< 20)
Submitted August 5, 2008

After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of mo … More

0 Replies Reply Report this Post

News & Commentary

3 Companies That Put the "Tech" in "Biotech"

From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."

Novartis Considers Possible Bid for Actavis

Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness

Jolie's personal experiences brings the dangers of breast cancer into new light and also gives hope to current and future breast cancer sufferers thanks to improving therapies and diagnostic tests.

Why Bristol-Myers Is Soaring

The speculation centers around Bristol-Myers' cancer trial results.

The Hidden Opportunity of the Novel Coronavirus

With the potential for an epidemic at hand, we look at things from a glass-half-full perspective.

Big Pharma's Biggest Winners

A Fool recaps first-quarter earnings bright spots around the pharmaceutical industry.

Correction to Story on Novartis's FDA Approval for Ilaris

6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II

Should We Get Bullish on This Fast Growing Healthcare Company?

Novartis: FDA Approves Ilaris for Serious Form of Childhood Arthritis

See More NVS News...

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks